Jakub Dobruch

Postgraduate School of Molecular Medicine

Papers

1

Total Citations

12

H-Index

1

About

Dr. Jakub Dobruch is a leading urologic oncologist whose research has significantly advanced the surgical management of bladder cancer, particularly through the refinement of minimally invasive techniques. His work focuses on optimizing outcomes for patients with muscle-invasive bladder cancer, with a major contribution being the rigorous evaluation of pure laparoscopic radical cystectomy (LRC). In his highly cited 2010 study, Dr. Dobruch reported on a series of 47 LRC procedures, providing critical data on perioperative safety, pathological outcomes, and the feasibility of both urinary conduits and neobladder reconstructions. This work helped establish LRC as a viable, attractive alternative to open surgery during a pivotal era in urologic oncology. With over a decade of influence, his findings continue to inform clinical decision-making and training, demonstrating his lasting impact on surgical practice. Dr. Dobruch’s dedication to evidence-based innovation has made him a respected voice in the field, guiding the evolution of bladder cancer care toward less invasive, patient-centered solutions.

Research Focus

Key Achievements

1
H-Index
1
Papers
12
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Is Pure Laparoscopic Radical Cystectomy Still an Attractive Solution for the Treatment of Muscle-Invasive Bladder Cancer?
12 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Postgraduate School of Molecular Medicine

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago